Mitsubishi UFJ Trust & Banking
PRAX icon

Mitsubishi UFJ Trust & Banking’s Praxis Precision Medicines PRAX Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$441K Buy
+1,317
New +$417K ﹤0.01% 1100

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's PRAX Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 1,317 shares worth $441K. The stake represents ﹤0.01% of the portfolio and ranks #1100 among its holdings.

309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 1,317 shares of Praxis Precision Medicines worth $441K as of Q2 2026.
  • Praxis Precision Medicines was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1100 holding.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.